Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Prepaid Assets (2016 - 2026)

Aytu Biopharma has reported Prepaid Assets over the past 14 years, most recently at $6.6 million for Q4 2025.

  • Quarterly Prepaid Assets rose 7.62% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 7.62% year-over-year, with the annual reading at $5.6 million for FY2025, 10.61% up from the prior year.
  • Prepaid Assets was $6.6 million for Q4 2025 at Aytu Biopharma, up from $5.2 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $71.1 million in Q2 2023 and troughed at $624000.0 in Q4 2022.
  • The 5-year median for Prepaid Assets is $5.6 million (2025), against an average of $11.1 million.
  • Year-over-year, Prepaid Assets crashed 94.48% in 2022 and then surged 11128.91% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $11.3 million in 2021, then crashed by 94.48% to $624000.0 in 2022, then skyrocketed by 113.62% to $1.3 million in 2023, then surged by 362.64% to $6.2 million in 2024, then grew by 7.62% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Prepaid Assets are $6.6 million (Q4 2025), $5.2 million (Q3 2025), and $5.6 million (Q2 2025).